Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1154 studies found for:    glioblastoma
Show Display Options
RSS Create an RSS feed from your search for:
glioblastoma
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
TRC105 for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: TRC105
2 Completed A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
3 Unknown  A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
Condition: Glioblastoma
Intervention: Procedure: FDG-PET
4 Recruiting Ketogenic Diet Adjunctive to Salvage Chemotherapy for Recurrent Glioblastoma:a Pilot Study
Condition: Glioblastoma Multiforme
Interventions: Dietary Supplement: Ketogenic diet;   Dietary Supplement: Standard diet
5 Recruiting Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Drug: F-MISO;   Other: Cerebral magnetic resonance imagery;   Drug: Bevacizumab;   Other: Clinical examination
6 Completed Evaluation of [18F]-FMISO for Non Operated Glioblastoma
Condition: Glioblastoma
Intervention: Procedure: 18F]-FMISO PET-CT
7 Active, not recruiting Disease Progression and Treatment-induced Alterations in Glioblastoma
Condition: Brain Tumor
Intervention: Genetic: analyze systematically morphological and molecular changes associated with glioblastoma progression and therapy-resistance
8 Recruiting Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Condition: Glioblastoma Multiforme
Intervention: Other: ketogenic diet
9 Withdrawn A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Drug: TMZ plus concurrent re-irradiation;   Drug: Temozolomide
10 Recruiting Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Radiation: Radiochemotherapy
11 Terminated Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: TLN-4601
12 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
13 Recruiting Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients
Condition: Glioblastoma Multiforme
Intervention: Drug: PQR309
14 Completed PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
Condition: Glioblastoma
Interventions: Drug: PTK787/ZK 222584;   Drug: Temozolomide;   Procedure: Radiation Therapy
15 Recruiting Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma;   Recurrent Glioblastoma;   Brain Tumor
Intervention: Drug: Tesevatinib
16 Unknown  Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
Condition: Glioblastoma
Intervention: Drug: Temozolomide
17 Completed Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
Condition: Glioblastoma
Intervention: Radiation: Magnetic Resonance Imaging (MRI)
18 Completed Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Condition: Glioblastoma
Intervention: Drug: nelfinavir
19 Recruiting Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)
Condition: Glioblastoma
Intervention: Biological: Personalized cellular vaccine
20 Terminated
Has Results
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Drug: Everolimus;   Procedure: Surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.